Glox Therapeutics

Pre-clinical

Oxford, United KingdomFounded 2019gloxtherapeutics.com

Develops novel antibiotics targeting Gram-negative bacterial infections.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $42.2M

Develops novel antibiotics targeting Gram-negative bacterial infections.

Biologics

Total raised:$42.2M

Series A$37MSR OneNov 15, 2023

Seed$5.2MUK Innovation & Science Seed FundJun 15, 2022